
The Curious Case of FDA’s Dr. Peter Marks
Why should you care about the curious case of Dr. Peter Marks, MD, PhD? The recently resigned head of the FDA Center for Biologics Evaluation and Research (CBER)? Because Dr. Peter Marks provides an excellent case study of what happens when the government settles for acceptable instead of excellent in scientific administrator (bureaucrat) positions.








